Active Ingredient History
Meprednisone, also known as NSC-63278 and Betapar, is a glucocorticoid receptor agonist.It has anti-inflammatory and immunosuppressive activity. It was approved since 1978, but its marketing in USA was discontinied since. Meprednisone is marketed in Argentina under trade name Copytren for treatment of rheumatic diseases, diseases of collagen, dermatological, gastrointestinal, respiratory and ophtalmological diseases. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Collagen Diseases (approved 1978)
Gastrointestinal Diseases (approved 1978)
Respiration Disorders (approved 1978)
Rheumatic Diseases (approved 1978)
Skin Diseases (approved 1978)
Abortion, Habitual (Phase 3)
Abortion, Spontaneous (Phase 2)
Acanthamoeba Keratitis (Phase 2)
Adrenal Hyperplasia, Congenital (Phase 4)
Adrenal Insufficiency (Phase 3)
Arthritis, Psoriatic (Phase 3)
Arthritis, Rheumatoid (Phase 2)
Aspergillosis, Allergic Bronchopulmonary (Phase 2/Phase 3)
Asthma (Phase 4)
Atherosclerosis (Phase 1/Phase 2)
Bell Palsy (Phase 4)
Bites and Stings (Phase 3)
Canavan Disease (Phase 1/Phase 2)
Cataract (Phase 4)
Churg-Strauss Syndrome (Phase 3)
Cognition Disorders (Phase 2)
Colitis, Ulcerative (Phase 2)
Collagen (Phase 4)
Conjunctivitis, Allergic (Phase 2)
Corneal Diseases (Phase 4)
Corneal Edema (Phase 4)
Coronavirus Infections (Phase 3)
Deficiency Diseases (Phase 4)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 2)
Diabetic Retinopathy (Phase 4)
Down Syndrome (Phase 3)
Drugs, Investigational (Phase 2)
Dry Eye Syndromes (Phase 4)
Edema (Phase 4)
Endodontics (Phase 2)
Esophageal Stenosis (Phase 4)
Eye Diseases, Hereditary (Phase 4)
Facial Nerve Diseases (Phase 4)
Facial Paralysis (Phase 4)
Fasting (Phase 4)
Fertilization in Vitro (Phase 2)
General Surgery (Phase 4)
Giant Cell Arteritis (Phase 2)
Glaucoma (Phase 4)
Glaucoma, Open-Angle (Phase 3)
Graves Disease (Phase 3)
Healthy Volunteers (Phase 1)
Hemodynamics (Phase 2)
Hemorrhage (Phase 3)
Hepatic Encephalopathy (Phase 2)
Herpes Labialis (Phase 4)
Hodgkin Disease (Phase 3)
Hyperthyroidism (Phase 3)
Immune System Diseases (Phase 2)
Immunoglobulin G4-Related Disease (Phase 2)
Infections (Phase 3)
Infertility (Phase 2/Phase 3)
Inflammation (Phase 4)
Ischemic Stroke (Phase 3)
Keratoconus (Phase 4)
Keratoplasty, Penetrating (Phase 4)
Kidney Diseases (Phase 3)
Leber Congenital Amaurosis (Phase 2)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 3)
Leukemia, Myeloid, Acute (Phase 1/Phase 2)
Leukemia, T-Cell (Phase 1)
Lichen Planus (Phase 3)
Liver Diseases (Phase 2)
Liver Failure, Acute (Phase 2)
Lupus Nephritis (Phase 4)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Follicular (Phase 4)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Macular Degeneration (Phase 4)
Macular Edema (Phase 4)
Melanoma (Phase 2)
Mucocutaneous Lymph Node Syndrome (Phase 3)
Multiple Sclerosis (Phase 3)
Muscular Diseases (Phase 4)
Muscular Dystrophy, Duchenne (Phase 1)
Myocardium (Phase 2)
Nasal Polyps (Phase 3)
Neointima (Phase 2)
Neonatology (Phase 3)
Neoplasms (Phase 2)
Nephrosis, Lipoid (Phase 4)
Nephrotic Syndrome (Phase 4)
Obstetric Labor, Premature (Phase 3)
Ocular Hypertension (Phase 3)
Oncogenes (Phase 2)
Optic Neuropathy, Ischemic (Phase 2)
Orbital Pseudotumor (Phase 3)
Otitis Media with Effusion (Phase 4)
Pain (Phase 4)
Pain, Postoperative (Phase 4)
Paralysis (Phase 3)
Patient Preference (Phase 4)
Pemphigoid, Benign Mucous Membrane (Phase 2/Phase 3)
Pemphigoid, Bullous (Phase 2/Phase 3)
Polymyalgia Rheumatica (Phase 3)
Premature Birth (Phase 3)
Prostatic Neoplasms (Phase 2)
Psychotic Disorders (Phase 2)
Pterygium (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 4)
Pulpitis (Phase 4)
Purpura, Thrombotic Thrombocytopenic (Phase 2/Phase 3)
Refractive Surgical Procedures (Phase 4)
Renal Dialysis (Phase 2)
Retinal Detachment (Phase 4)
Retinal Vein Occlusion (Phase 4)
Retroperitoneal Fibrosis (Phase 4)
Sarcoidosis (Phase 4)
Sarcoidosis, Pulmonary (Phase 4)
Sarcoma (Phase 3)
Schizophrenia (Phase 2)
Scleroderma, Systemic (Phase 2)
Sinusitis (Phase 4)
Spasms, Infantile (Phase 2/Phase 3)
Substance Withdrawal Syndrome (Phase 3)
Takayasu Arteritis (Phase 3)
Testicular Neoplasms (Phase 3)
Treatment Outcome (Phase 4)
Uveitis (Phase 4)
Vascular Remodeling (Phase 2)
Vitreoretinal Surgery (Phase 4)
Wet Macular Degeneration (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
